CVS Health (CVS) stock gains as the company beats Q2 2025 forecasts with strong insurance and pharmacy performance, and ...

CVS Health’s CVS Pharmacy and Consumer Wellness (“PCW”) segment has seen steady growth in recent months, with revenues up 11.1% year over year in the first quarter of 2025. Performance was ...

CVS Health ’s CVS Pharmacy and Consumer Wellness (“PCW”) segment has seen steady growth in recent months, with revenues up 11.1% year over year in the first quarter of 2025. Performance was supported ...

The healthcare giant raised its full-year adjusted EPS guidance to a range of $6.30 to $6.40, up from its previous outlook of ...

CVS beats Q2 earnings and revenue estimates, lifts full-year forecast. Stock surges over 8% in premarket trading, up 39% YTD.

In a statement, CVS Chief Executive David Joyner highlighted "a significant and durable recovery" at Aetna, and "strong retention" at CVS Caremark. Last quarter, CVS said that Aetna is exiting the ...

In Pharmacy and Consumer Wellness, CVS maintains a strong retail pharmacy script share position despite the reduced store count.

Personal safety devices for women often prioritize portability, discreet design, and ease of use under stress. These tools ...

CVS CEO David Joyner pointed to strength in its retail pharmacy and improvement in its insurance unit, Aetna, which is ...

CVS Health beats on Q2 earnings and raises 2025 EPS outlook, lifting shares nearly 8% on strong segment growth and margin ...

Aetna saw its medical benefits ratio increase months after CVS announced it would exit the ACA individual market due to struggling performance.